The University of Chicago Header Logo

Connection

Thomas Gajewski to Immunity, Active

Back to Details
This is a "connection" page, showing publications Thomas Gajewski has written about Immunity, Active.
Thomas Gajewski
Connection Strength
0.031
Immunity, Active
  1. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J Immunol. 1996 Apr 15; 156(8):2909-17.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.